Prescient Therapeutics Ltd has released a press release.
Response to ASX Price Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Earlier from Prescient Therapeutics
- PTX signs CAR-T agreement with Peter MacCallum
- March 2021 Quarterly Update and Appendix 4C
- PTX-200 AML Trial Progresses to Higher Dose
- December 2020 Quarterly Update and Appendix 4C
- PTX announces 3 next-gen CAR-T programs with OmniCAR
Later from Prescient Therapeutics
- PTX Completes CAR-T Manufacturing Milestone for OmniCAR
- PTX successful immunogenicity testing of OmniCAR
- PTX-100 trial advances following successful Phase 1b
- June 2021 Quarterly Activities and Appendix 4C
- Appendix 4E and 2021 Annual Report
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics